Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Total Net Revenue $ 3,570,035 $ 2,974,162 $ 6,333,237 $ 4,579,358
Total Cost of Sales 2,154,138 1,443,211 3,930,778 2,497,445
Gross Profit 1,415,897 1,530,951 2,402,459 2,081,913
Operating Expenses:        
Research and development 425,670 431,856 912,296 870,636
Selling, general and administrative 1,476,719 1,291,103 2,799,767 2,568,006
Depreciation and amortization 17,043 16,628 33,975 33,543
Total Operating Expenses 1,919,432 1,739,587 3,746,038 3,472,185
Operating loss (503,535) (208,636) (1,343,579) (1,390,272)
Other Income (Expenses):        
Interest income (expense), net (15,040) 4,054 (20,600) 1,524
Total Other Income (Expense) (15,040) 4,054 (20,600) 1,524
Loss before Provision for Income Taxes (518,575) (204,582) (1,364,179) (1,388,748)
Provision for Income Taxes 0 2,000 0 2,000
Net loss attributable to common stockholders $ (518,575) $ (206,582) $ (1,364,179) $ (1,390,748)
Net loss per common share:        
Basic - net income (loss) attributable to common stockholders $ (0.00) $ (0.00) $ (0.01) $ (0.01)
Diluted - net income (loss) attributable to common stockholders $ (0.00) $ (0.00) $ (0.01) $ (0.01)
Weighted Average Common Shares Outstanding- basic 135,085,519 133,989,919 134,447,460 133,843,329
Weighted Average Common Shares Outstanding - diluted 135,085,519 133,989,919 134,497,822 133,843,329
Product [Member]        
Total Net Revenue $ 3,380,892 $ 2,820,805 $ 5,967,561 $ 4,324,463
Total Cost of Sales 2,077,066 1,376,729 3,767,664 2,370,966
Recurring [Member]        
Total Net Revenue 189,143 153,357 365,676 254,895
Total Cost of Sales $ 77,072 $ 66,482 $ 163,114 $ 126,479